Savv-e Revenue and Competitors
Estimated Revenue & Valuation
- Savv-e's estimated annual revenue is currently $8M per year.
- Savv-e's estimated revenue per employee is $148,500
Employee Data
- Savv-e has 54 Employees.
Savv-e's People
Name | Title | Email/Phone |
---|---|---|
1 | Production Manager | Reveal Email/Phone |
Savv-e Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.3M | 40 | -7% | N/A | N/A |
#2 | $196.6M | 851 | N/A | N/A | N/A |
#3 | $1.9M | 19 | N/A | N/A | N/A |
#4 | $2.8M | 24 | N/A | N/A | N/A |
#5 | $2.5M | 22 | N/A | N/A | N/A |
#6 | $2.8M | 24 | N/A | N/A | N/A |
#7 | $8M | 54 | N/A | N/A | N/A |
#8 | $1.1M | 11 | N/A | N/A | N/A |
#9 | $337M | 1459 | N/A | N/A | N/A |
#10 | $45.9M | 253 | N/A | N/A | N/A |
What Is Savv-e?
N/A
Total Funding
54
Number of Employees
$8M
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator
Savv-e News
2022-04-13 - Analyzing Neovasc (NASDAQ:NVCN) & enVVeno Medical ...
... Device Designation from the U.S. Food and Drug Administration, and is currently being evaluated in the SAVVE U.S. clinical trial.
2022-04-06 - enVVeno Medical Announces New U.S. VenoValve(R) Patent
The VenoValve is currently being evaluated in leading hospitals throughout the U.S. in the ongoing SAVVE U.S pivotal trial.
2022-03-22 - enVVeno Medical Reports Fourth Quarter and Year-End 2021 ...
Successfully completed 9 VenoValve surgeries and 16 sites currently activated in the Company's SAVVE U.S. pivotal trial for the VenoValve;...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $7M | 54 | 50% | N/A |
#2 | $11M | 58 | 4% | N/A |
#3 | $13.3M | 58 | 12% | N/A |
#4 | $5.4M | 59 | -2% | N/A |
#5 | $5.8M | 63 | 0% | N/A |